Gates Foundation Collaborates with the Consortium of Life Sciences Companies to Address Challenges Against the Pandemic COVID-19

 Gates Foundation Collaborates with the Consortium of Life Sciences Companies to Address Challenges Against the Pandemic COVID-19

Gates Foundation Collaborates with the Consortium of Life Sciences Companies to Address Challenges Against the Pandemic COVID-19

Shots:

  • Novartis along with multiple pharmaceutical companies work in collaboration with the Gates Foundation to accelerate the development, manufacturing and delivery of vaccines, diagnostics and other treatments to combat COVID-19
  • The collaboration will bring a range of assets, resources, and expertise required to identify effective & scalable solutions targeting the pandemic
  • Fifteen pharmaceutical companies will share their molecular compound libraries with the COVID-19 Therapeutics Accelerator launched by the Gates Foundation, Wellcome, and Mastercard for screening the potential of therapies against COVID-19

Click here ­to­ read full press release/ article | Ref: Novartis | Image: BORGEN Magazine

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post